AbbVie Inc
(WBO:ABBV)
€
216.1
(0%)
Market Cap: 379.76 Bil
Enterprise Value: 435.53 Bil
PE Ratio: 120.58
PB Ratio: 0
GF Score: 71/100 Abbvie Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 20, 2020 / 02:50PM GMT
Release Date Price:
€83.2
(+0.97%)
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Hello, and welcome to day 3 of the UBS Healthcare Conference. My name is Navin Jacob, senior analyst covering large-cap pharmaceuticals and smid-cap biotech. Our next presentation and fireside chat is with AbbVie. I'm very happy to have with me Mike Severino, Vice Chairman and President of AbbVie; as well as Rob Michael, CFO of AbbVie; as well as Liz Shea, Head of Investor Relations. Thank you all for joining us today.
Robert A. Michael
AbbVie Inc. - Executive VP & CFO
Thanks for having us.
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Pleasure.
Questions & Answers
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
We are just going to
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot